To the Editor.—
Two recent articles addressed some of the arguments for and against treating actinic keratoses (AKs).1,2 Although Dodson et al1 presented a patient-oriented perspective (the risk of malignant conversion over 10 years), and Marks2 presented his practical and economic perspective, it is surprising that neither article addressed the most important justification for the treatment of AKs—ie, the AK is much more likely to convert into a squamous cell carcinoma (SCC) than the surrounding skin. The ability to identify high-risk individuals is of obvious importance in any screening program. The ability to identify high-risk areas of human tissue is exceptionally useful and unusual in medicine. We present our perspective on the relative risk of malignant transformation (to SCCs) in AKs compared with normal skin.Current concepts regarding malignant transformation of AKs to SCCs are largely based on work of Marks et al.3 They conducted a
Mostow EN, Johnson TM. Malignant Transformation From Actinic Keratoses to Squamous Cell Carcinomas. Arch Dermatol. 1992;128(4):560–561. doi:10.1001/archderm.1992.01680140144022
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: